Publications

Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

 30
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

Tags:

Previous Article

Driver of cardiac injury after coronary microembolization

Next Article

How glioblastoma tumors dodge chemotherapy

Related Posts

What Is Renal Cell Carcinoma?

What Is Renal Cell Carcinoma?

 84

Host and microbiome lipid metabolism in colorectal cancer development and therapy

Host and microbiome lipid metabolism in colorectal canc...

 145

Thyroid hormone remodels cortex to coordinate body-wide metabolism and exploration

Thyroid hormone remodels cortex to coordinate body-wide...

 70